 the genomic basis for this variability through a series of interrelated studies addressing a breadth of modern and classical anticancer agents. This will include both laboratory and translational clinical studies. There are two main objectives of this research: (1) to develop the methodology - utilizing both instrumental and radiochemical neutron activation analysis - to determine selected element
the genomic basis for this variability through a series of interrelated report cover a breadth of mod and authoritative anticancer agents. This will include both laboratory and translational clinical study. There are two main aim of this research: (1) to develop the methodology - utilize both instrumental and radiochemical neutron activation psychoanalysis - to determine selected element
 thf genomic basis for this variability thtoygh a veries of intefrelated studies addressing e brwadth of modern and classicxl anticajcer agebts. Uhis will include both lanjratkvy anb vranslational ckinical stgdies. There ara gwl main objectives of this research: (1) to devrllp the methodojogy - utimpzlng both instrumental and radiocgemical neutron actifation analysis - to determlne delected element
the genomic basis for this variability through of studies addressing breadth of modern will both laboratory and clinical studies. There two main objectives of this research: to develop the methodology - utilizing both instrumental and radiochemical neutron activation analysis to determine selected element
 the genomic basis for this varIability thRough A seRieS oF intErreLated studies adDRessIng a breadth of modern and ClassIcAL antICaNcer aGents. ThIS wILL inClUdE boTh LAbOratoRy aNd transLational clIniCaL studies. TherE ArE two main obJecTives of this rEseArch: (1) to DeVelOP the mEthOdoloGy - utilIZing boTh instrumEnTAl and rADiochemICAl NeutRon activation analYSiS - To determine selEcted eLeMEnT
 the genomic basis for thi s variabil ity t hro ugh  a  ser iesof interrelate d  stu dies addressing a brea dth o fm oder n  a nd cl assical an t i can ce rage nt s .Thiswil l inclu de both la bor at ory and tran s la tional cli nic al studies.The re are  t wom ain o bje ctive s of t h is res earch: (1 )t o deve l op them e th odol ogy - utilizing b o th instrumental a nd rad io c he m i cal  ne utron acti va tiona nalysis -t o det e rmine selecte d element
 the_genomic basis_for this variability through_a series_of_interrelated studies_addressing_a breadth of_modern and classical_anticancer agents. This will_include both laboratory_and_translational clinical studies. There are two main objectives of this research: (1) to develop_the_methodology -_utilizing_both_instrumental and radiochemical neutron activation_analysis - to determine selected_element